Oxystin

Oxytocin; l-Cysteinyl-l-tyrosyl-l-isoleucyl-l-glutamyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-leucylglycinamide cyclic (1→6)-disulfide; 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.; 1: PN: WO0178758 SEQID: 1 claimed protein; 1: PN: WO2004000993 PAGE: 53 claimed protein; 1: PN: WO2011145051 SEQID: 1 claimed protein; 3-Isoleucine-8-leucine vasopressin; 74: PN: US20090175821 PAGE: 403 claimed protein; Alpha-hypophamine; Atonin O; Di-sipidin; Endopituitrina; Glycinamide, L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucyl-, cyclic (1→6)-disulfide; Hyphotocin; Intertocine S; L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1→6)-disulfide; Nobitocin S; Orasthin; Oxystin; Partocon; Perlacton; Pitocin; Piton S; Presoxin; Synpitan; Synpitan forte; Synthetic oxytocin; Syntocin; Syntocinon; Syntocinone; Uteracon; Vasopressin, 3-L-isoleucine-8-L-leucine-; [1-Hemicystine]-oxytocin; α-Hypophamine

CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N

InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

IUPAC name: (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide